Autopsy report · NCT01736800

Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors

“No enrollment and PI requested study termination per IRB system.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

The Methodist Hospital Research Institute

Sponsor type

University, hospital or other

Conditions

Central Nervous System (CNS) Metastases; Brain Metastases

Interventions

Topotecan; Temozolomide

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
  “No participants enrolled. Study terminated at PI's discretion” (74% match in meaning)
• Dexmedetomidine Cycling and Sleep in the Pediatric ICU
  “No enrollment, IRB closed” (73% match in meaning)
• Pain Control Without Opioids
  “Enrollment was never initiated and the PI is leaving the institution so the study is closing.” (73% match in meaning)
• Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
  “Study was never initiated. No IRB approval obtained, and no participants enrolled.” (73% match in meaning)
• Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy
  “PI left institution and no subjects enrolled.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.